Title : Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication.

Pub. Date : 2021 Jan 1

PMID : 33347311






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The inhibitors of the virus entry to cells and RdRp, such as Arbidol, remdesivir, favipiravir, EIDD-2081, and ribavirin, are in clinical trials, while most of the protease inhibitors are mainly calculated by molecular docking technology, which needs in vivo and in vitro experiments to prove the effect for SARS-CoV-2. remdesivir ORF1a polyprotein;ORF1ab polyprotein Severe acute respiratory syndrome coronavirus 2